Recently reported in Medical Dialogues, a new study from the Study of Women’s Health Across the Nation (SWAN) has highlighted a link between diabetes, insulin resistance, and the prevalence of uterine fibroids in midlife women.
Published in The Journal of Clinical Endocrinology & Metabolism, the research found that the incidence of fibroids appears to decrease for individuals effectively managing diabetes, particularly those using metformin.
The SWAN study followed over 2,500 women for nearly two decades, examining diabetes-related factors across 13 follow-up visits. Results indicated a 28% lower occurrence of fibroids in diabetic participants, with a nearly 50% decrease observed among those using metformin, a type 2 diabetes medication.
Menopausal status also affected outcomes, with insulin resistance linked to a higher fibroid risk in premenopausal women but not in those transitioning to menopause. Although these recent findings offer intriguing insights into the relationship between diabetes and fibroids, further research is needed to understand the connection and its implications for treatment.
While understanding overall health and medication use can help manage fibroids, it’s important to consult with a healthcare provider for personalized advice. They can assess individual circumstances and recommend the most appropriate treatment options.
To learn more about the relationship between diabetes, insulin resistance, and fibroids, click here.
